- 全部删除
您的购物车当前为空
MRTX-9768 是一种有效的、选择性的、具有口服活性的 PRMT5-MTA 复合体抑制剂,可选择性靶向 MTAP/CDKN2A 缺失的肿瘤。

MRTX-9768 是一种有效的、选择性的、具有口服活性的 PRMT5-MTA 复合体抑制剂,可选择性靶向 MTAP/CDKN2A 缺失的肿瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,630 | In stock | |
| 2 mg | ¥ 3,930 | In stock | |
| 5 mg | ¥ 6,160 | In stock | |
| 10 mg | ¥ 8,290 | In stock | |
| 25 mg | ¥ 12,300 | In stock | |
| 50 mg | ¥ 16,600 | In stock | |
| 100 mg | ¥ 22,300 | In stock |
MRTX9768 相关产品
| 产品描述 | MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors. |
| 靶点活性 | Cell proliferation:861 nM(HCT116 MTAP-WT cells), Cell proliferation:11 nM(HCT116 MTAP-del cells), SDMA:544 nM(HCT116 MTAP-WT cells), SDMA:3 nM(HCT116 MTAP-del cells) |
| 体外活性 | MRTX-9768, a potent inhibitor of SDMA and cell proliferation in HCT116 MTAP-del cells (SDMA IC50 3 nM; prolif. IC50 11 nM) with marked selectivity over HCT116 MTAP-WT cells (SDMA IC50 544 nM; prolif. IC50 861 nM). |
| 体内活性 | In xenograft studies, oral administration of MRTX-9768 demonstrates dose-dependent inhibition of SDMA in MTAP-del tumors, with less SDMA modulation observed in bone marrow[1]. |
| 分子量 | 424.43 |
| 分子式 | C24H17FN6O |
| CAS No. | 2629314-68-5 |
| Smiles | Cn1ncc(c1-c1c(F)cc2ccccc2c1C#N)-c1ccc2c(c1)c(CN)n[nH]c2=O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 35 mg/mL (82.46 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.71 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容